Cerebral fluorine-18 fluorodeoxyglucose positron emission tomographic findings in X-linked adrenoleukodystrophy

被引:3
作者
Bakheet, S
Al-Essa, M
Patay, Z
Al-Watban, J
Dhaunsi, G
Powe, J
Ozand, PT
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Radiol, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Riyadh 11211, Saudi Arabia
关键词
demyelinating disease; fluorine-18 fluorodeoxygluclose positron emission tomographic brain scan; white matter; X-linked adrenoleukodystrophy;
D O I
10.1097/00003072-199905000-00021
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Fluorine-18 fluorodeoxygluclose (F-18 FDG) scan findings are reported in a 10-year-old boy with X-linked adrenoleukodystrophy (X-ALD) who was evaluated for progressive encephalopathy, which is characteristic of the disease. The brain MRI study showed typical white matter abnormalities in the parietal and occipital lobes. The subsequent F-18 FDG revealed hypometabolic activity in the cerebral cortex, most prominently in the occipital lobes and particularly in the visual cortex. There was evidence of a gradient of diffusely increased glucose metabolism in most of the cerebral white matter. These changes were most prominent in the parietal and temporal lobes and less marked in the occipital areas. The functional changes demonstrated by the F- 18 FDG scan were more extensive than the structural abnormalities demonstrated by MRI and better correlated with the the patient's rapid neurologic deterioration. Brain F-18 FDG positron emission tomographic (PET) imaging is helpful in the accurate delineation of the involved areas and in monitoring the progression of the demyelinating process in the different stages of this disease. The results also suggest that F-18 FDG PET may be useful in detecting demyelinating diseases associated with inflammation.
引用
收藏
页码:364 / 365
页数:2
相关论文
共 5 条
[1]   ADRENOLEUKODYSTROPHY - CORTICAL HYPOPERFUSION DEMONSTRATED WITH TC-99M-HMPAO SPECT [J].
ALSUHAILI, AR ;
HERTECANT, J ;
SZTRIHA, L .
JOURNAL OF CHILD NEUROLOGY, 1994, 9 (03) :284-286
[2]   COMPUTED-TOMOGRAPHY, MAGNETIC-RESONANCE-IMAGING, POSITRON EMISSION TOMOGRAPHY AND EVOKED-POTENTIALS AT EARLY STAGE OF ADRENOLEUKODYSTROPHY [J].
IINUMA, K ;
HAGINOYA, K ;
HANDA, I ;
KOJIMA, A ;
FUEKI, N ;
AIKAWA, J ;
ITO, M ;
HATAZAWA, J ;
IDO, T .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 159 (03) :195-203
[3]   REGIONAL CEREBRAL BLOOD-FLOW MEASUREMENT USING TC-99M HMPAO SPECT IN A PATIENT WITH ADRENOLEUKODYSTROPHY [J].
MATSUDA, H ;
UESUGI, H ;
KAMATA, K ;
SUNOHARA, N ;
YAGISHITA, A .
CLINICAL NUCLEAR MEDICINE, 1995, 20 (01) :52-54
[4]  
VANDERKNAAP MS, 1995, MAGNETIC RESONANCE M, P129
[5]  
VOLKOW ND, 1987, J NUCL MED, V28, P524